|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 40.05 USD | +2.69% |
|
+18.35% | +275.35% |
| 08-21 | Needham Initiates Faeth Therapeutics at Buy With $56 Price Target | MT |
| 08-17 | Faeth Therapeutics Shares Rise on FDA Fast-Track Designation for Cancer Treatment | DJ |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| FTH | Delayed | |
CBOE
| FTH | Real-time | |
|
Deutsche Boerse AG
| 4070 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 46.6 | 65.6 | 56.2 |
| Spread/Res. | -14.06% | -38.95% | -28.74% |
| Spread/Supp. | +22.22% | +75.12% | +125.13% |
| Support | 32.77 | 22.87 | 17.79 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- FTH Stock
- Charts Faeth Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
